Defeating the biggest challenges

Aeternitas Therapeutics was founded on a singular premise: that the "undruggable" nature of p53 is not a biological absolute, but an engineering challenge.

By combining computational biology (AlphaFold 3) with rational protein design, we are rewriting the rules of oncology. Our headquarters are located in the heart of Scandinavian innovation in Gothenburg, Sweden.